HLA-C and cancer: Moreover, to resolve the diversity and variation of MHC molecules and antigens in human population, LPPC/MP/Ab complexes showed remarkable potential and technological advances in human diseases such as cancers or autoimmune diseases for personalized precision immunotherapy.